Ultra Market Research | Biotechnology Reagents and Kits Market
Biotechnology Reagents and Kits Market
Report ID : 597
Category : Pharmaceuticals
No Of Pages : 145
Published on: July 2024
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Biotechnology Reagents and Kits Market Overview The global biotechnology reagents and kits market was valued at US$ XX billion in 2023 and is projected to reach approximately US$ XX billion by 2033, with a compound annual growth rate (CAGR) of XX% from 2024 to 2033. The market's expansion is significantly influenced by the evolution of molecular biology kits, which have advanced from basic DNA cloning protocols to sophisticated reagent sets that enable whole genomic sequencing. Initially, these kits faced criticism from some researchers who felt they undermined the fundamental understanding of reagent creation. However, they have since become crucial in biological sciences, streamlining research processes and enhancing the efficiency of complex experiments. This shift has driven the growth of the biotechnology reagents and kits market, reflecting the increasing reliance on these kits in scientific research and experimentation.
Market Dynamics
The biotechnology reagents and kits market is rapidly expanding, fueled by the essential role of reagents and analytical kits in scientific research and experimentation. Reagents, which include substances that cause chemical reactions or detect their occurrence, and kits that facilitate such processes, are crucial for the detection and quantification of targets. ELISA kits, for example, are frequently cited in scientific literature, highlighting their significance. The market also covers diagnostic devices and reagents used in molecular diagnostics, ELISA, lateral flow tests (LFT), and sample transport, underscoring its broad scope. Companies like R&D Systems support the life science research community with commonly used ELISAs, further amplifying market growth. The market continues to evolve with a diverse range of biological reagents and diagnostic kits, meeting the demand for effective and reliable laboratory testing solutions.
Recent Developments
In February 2024, Takara Bio introduced large-scale single-cell next-generation sequencing (NGS) profiling technologies, which are expected to revolutionize biomarker discovery.
In April 2024, Bio-Rad launched an ultrasensitive multiplexed digital PCR assay for detecting breast cancer mutations in clinical research.
Regional Stance
North America: This region holds the largest market share and is a central hub for biotechnology innovation. The United States, in particular, exhibits steady growth, with an average annual increase of 1.5% in the biotech sector. The region's leadership in biotech is exemplified by companies such as Eli Lilly and Company, which contribute to advancements in pharmaceuticals and biologics. North America's continued innovation and development efforts make it a key player in shaping the global biotechnology market.
Asia-Pacific: This region is expected to experience the fastest growth in the forecast period. India, a significant player in the biotechnology sector, ranks third in the Asia-Pacific region and among the top 12 globally. Karnataka, in particular, is noted as the biotechnology capital of India. The surge in biotech investment in the Asia-Pacific region is driven by factors such as a growing population, increasing healthcare demands, and supportive government policies. This dynamic environment positions the region as a crucial factor in the future of the biotechnology industry.
Market Segmentation
By Technology Cell Culture
The cell culture segment holds the largest market share in the biotechnology reagents and kits market, driven by reagents and supplements specifically designed for cell culture applications. These specialized products facilitate the growth and maintenance of various cell types under controlled conditions. In vitro cell culture systems provide researchers with essential tools for studying cell growth and differentiation, enhancing the understanding of how cells respond to different environmental conditions. Each cell culture system is meticulously crafted to meet the specific nutritional and metabolic requirements of the cells, emphasizing the importance of precision and customization in biotechnological advancements.
Sequencing
The sequencing segment is identified as the fastest-growing sector in the biotechnology reagents and kits market. Sanger sequencing kits and reagents support PCR amplification of targeted regions, cycle sequencing, and reaction cleanup. Next-generation sequencing kits and reagents provide tools for target selection, library construction, and template preparation. This growth in sequencing technologies highlights the industry’s focus on advancing genomic research and personalized medicine, driving innovation and progress within the biotechnology field.
By Kits Type Detection Kits
The detection kits segment commands the largest market share in the biotechnology reagents and kits market. These kits are designed for various medical tests that assist in disease diagnosis and detection. Diagnostic testing is critical for diagnosing diseases, monitoring conditions, predicting outcomes, and guiding treatment decisions. The growing demand for accurate and efficient diagnostic tools continues to drive innovation and expansion within this segment of the biotechnology market.
By Micro-Organisms Virus
The virus segment has the largest market share in the biotechnology reagents and kits market. ELISA assays are crucial for virus detection and diagnosis, offering safety, specificity, and rapid results by producing recombinant viral proteins. This functionality allows for quick responses to emerging viruses and new viral strains, even in the absence of traditional culturing methods. These kits are also used in educational settings, highlighting their importance in both virology education and public health initiatives. Bacteria
The bacteria segment is projected to be the most promising in the biotechnology reagents and kits market. Bacteria are increasingly used in cancer treatment due to their ability to stimulate immune responses that target and destroy cancer cells. They can activate T lymphocytes and cytokines to aid in tumor destruction and release substances that inhibit tumor growth. This potential for cancer therapy underscores the evolving role of bacteria in biotechnology, especially in oncology.
By Tested Parameters RNA
The RNA segment dominates the biotechnology reagents and kits market in terms of tested parameters. To meet the demand for isolating total RNA from diverse sample types with varying purity needs, Invitrogen offers a range of RNA extraction kits. These kits use various purification methods suited to different sample types and downstream applications, ensuring efficient and flexible RNA extraction. The use of TRIzol reagent combined with glass-fiber filter purification produces high-quality RNA free from residual proteins and lipids, highlighting the importance of RNA analysis in biotechnological research and diagnostics. DNA
The DNA segment is expected to experience rapid growth in the biotechnology reagents and kits market over the forecast period. DNA reagents are essential for various DNA-related processes, including sequencing, synthesis, mutagenesis, cloning, mapping, and PCR. These products include plasmids, buffers, labeling technologies, columns, and kits, catering to a wide range of research and diagnostic needs. DNA extraction kits, in particular, offer optimized protocols for efficient cell lysis and washing, essential for obtaining pure DNA from various sample types. This anticipated expansion emphasizes the crucial role of DNA analysis in advancing biotechnology.
By End User Healthcare
The healthcare segment holds the largest market share in the biotechnology reagents and kits market, reflecting the extensive adoption of biotechnological solutions in medical and pharmaceutical fields. Biotechnology plays a pivotal role in healthcare, contributing to the production of antibiotics, hormones (such as interferons and insulin), enzymes, vitamins, and toxins. These advancements significantly enhance medical innovation and therapeutic development, driving growth in the healthcare sector. Biotechnology’s impact on improving patient outcomes and addressing medical needs positions the healthcare segment at the forefront of market expansion. Food & Agriculture
In the biotechnology reagents and kits market, the food & agriculture segment is anticipated to be the most opportunistic during the forecast period. Biotechnology provides farmers with tools to enhance production efficiency and cost-effectiveness, such as genetically engineered crops that resist specific herbicides. Additionally, biotechnology enables the assessment of food product quality, safety, and nutritional value by testing for contaminants like pesticides and heavy metals. As biotechnology continues to revolutionize agricultural practices, this segment is poised for significant growth, reflecting the industry’s focus on innovation and sustainability.
Market Dynamics
Driver:
Rise of Sustainable Bioeconomy
The rise of the sustainable economy is a key driver. Advances in synthetic biology and the push towards sustainable circular economic models are boosting the demand for biotechnology reagents and kits. Synthetic biology, a burgeoning interdisciplinary research field, capitalizes on foundational advancements in molecular biology coupled with engineering design principles. Currently, the market is predominantly led by reagents, tools, and contract service providers offering synthetic DNA and molecular biology tool kits alongside software solutions.
Restraints:
Challenges in Accessing Molecular Biology Reagents
Challenges include the high cost of molecular biology reagents and issues with maintaining the cold chain, long-distance shipping delays, and complex customs regulations, which can hinder the adoption of these technologies in low-resource settings.Furthermore, the complexity of procedures and infrastructure required for reagent preparation often dissuades local production, thus constraining the expansion of the biotechnology reagents and kits market.
Opportunities:
Expanding CRISPR Technology
Expanding CRISPR technology presents a significant opportunity. The development of CRISPR-based diagnostic assays and the ability to produce Cas enzymes and crRNAs afford new avenues for growth in the biotechnology reagents and kits market. Although these assays may require more enzymes compared to PCR, particularly with the inclusion of an isothermal preamplification step, the negligible costs of buffers, primers, and oligos for crRNA synthesis create a compelling opportunity for growth within the biotechnology reagents and kits market.
Recent Developments
May 2023: Advances reported include DNA printing, bioengineered kidney constructs in space, and Revvity’s agreements with big pharma.
March 2023: Sartorius announced its acquisition of Polyplus, enhancing its capabilities in viral vector manufacturing.
January 2023: Trinity Biotech partnered with Imaware to deliver integrated diagnostic testing solutions in the digital health industry.
September 2022: ValitaCell joined Beckman Coulter Life Sciences, expanding its capabilities in the biotechnology field.
Key Players in the Biotechnology Reagents and Kits Market Abbott Laboratories Agilent Technologies Danaher Corp. Becton Dickinson & Company Bio-Rad Laboratories GE Healthcare Siemens Healthcare Merck KGaA Thermo Fisher Scientific Inc. Waters Corporation
By Kits Type Amplifications Kits Isolation Kits Purification Kits Detection Kits Others
By Micro-Organisms Virus Bacteria Fungi Parasites
By Tested Parameters RNA DNA Enzymes Proteins Others
By End User Healthcare Food & Agriculture Industrial Processing Natural Resource & Environment Others
By Geography North America U.S. Canada Europe Germany France United Kingdom Rest of Europe Asia Pacific China Japan India Southeast Asia Rest of Asia Pacific Latin America Brazil Rest of Latin America Middle East & Africa (MEA) GCC North Africa South Africa Rest of Middle East & Africa
2
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Biologics Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Biologics Market for the past year and forecasts for the next six years. Global Biologics Market. Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Biologics Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Biologics Market from different application industries in different regions.
By Kits Type Amplifications Kits Isolation Kits Purification Kits Detection Kits Others
By Micro-Organisms Virus Bacteria Fungi Parasites
By Tested Parameters RNA DNA Enzymes Proteins Others
By End User Healthcare Food & Agriculture Industrial Processing Natural Resource & Environment Others
By Geography North America U.S. Canada Europe Germany France United Kingdom Rest of Europe Asia Pacific China Japan India Southeast Asia Rest of Asia Pacific Latin America Brazil Rest of Latin America Middle East & Africa (MEA) GCC North Africa South Africa Rest of Middle East & Africa
